John W. McEvoy
YOU?
Author Swipe
View article: P116 Therapeutic dead-end: rapidly deteriorating anti-MDA5-associated interstitial lung disease despite aggressive management
P116 Therapeutic dead-end: rapidly deteriorating anti-MDA5-associated interstitial lung disease despite aggressive management Open
Introduction Anti-melanoma differentiation-associated gene 5 (MDA5) is a myositis-specific antibody associated with a unique clinical syndrome within the clinical amyopathic dermatomyositis (CADM) family. It can be associated with high ris…
View article: Ultra-Processed Food Consumption and Subclinical Cardiac Biomarkers: A Cross-Sectional Analysis of U.S. Adults in NHANES 2001–2004
Ultra-Processed Food Consumption and Subclinical Cardiac Biomarkers: A Cross-Sectional Analysis of U.S. Adults in NHANES 2001–2004 Open
Background/Objectives: Ultra-processed food consumption has been shown to be linked with clinical cardiovascular disease. This study aims to examine the associations of ultra-processed food consumption with biomarkers for subclinical-level…
View article: Using SCORE2 with a risk chart or online calculator: impact on model performance, treatment eligibility, and cardiovascular disease prevention
Using SCORE2 with a risk chart or online calculator: impact on model performance, treatment eligibility, and cardiovascular disease prevention Open
Aims Current European Cardiovascular Disease (CVD) prevention guidelines recommend 10-year risk assessment using the SCORE2 model to identify individuals eligible for preventive treatment. Risk can be estimated using conventional risk char…
View article: 2025 ESC Guidelines for the management of myocarditis and pericarditis
2025 ESC Guidelines for the management of myocarditis and pericarditis Open
View article: 2025 ESC Clinical Consensus Statement on mental health and cardiovascular disease: developed under the auspices of the ESC Clinical Practice Guidelines Committee
2025 ESC Clinical Consensus Statement on mental health and cardiovascular disease: developed under the auspices of the ESC Clinical Practice Guidelines Committee Open
ESC Clinical Consensus Statements, developed under the auspices of the ESC Clinical Practice Guidelines Committee, evaluate and summarize available evidence with the aim of assisting health professionals in proposing the best diagnostic or…
View article: Physician perspectives on Lp(a) testing and management in patients with cardiovascular disease: interviews from seven countries across five world health organization regions from INTERASPIRE
Physician perspectives on Lp(a) testing and management in patients with cardiovascular disease: interviews from seven countries across five world health organization regions from INTERASPIRE Open
Aims Lipoprotein(a) (Lp(a)) is a genetic causal risk factor for atherosclerotic cardiovascular disease (ASCVD), irrespective of ancestry. INTERASPIRE is an international cohort study of secondary prevention conducted in 14 countries from a…
View article: 2025 ESC/EACTS Guidelines for the management of valvular heart disease
2025 ESC/EACTS Guidelines for the management of valvular heart disease Open
International audience
View article: Psychological factors beyond the SMART2 model for predicting recurrent events in atherosclerotic cardiovascular disease patients
Psychological factors beyond the SMART2 model for predicting recurrent events in atherosclerotic cardiovascular disease patients Open
Aims Guidelines recommend using cardiovascular (CV) risk prediction models to support treatment decisions. Psychological factors such as depression, anxiety, and insomnia may affect CV risk. The aim is to evaluate the added value of these …
View article: Prevalence and prognostic importance of chronic kidney disease in patients with coronary heart disease: results from the combined EUROASPIRE IV and V studies
Prevalence and prognostic importance of chronic kidney disease in patients with coronary heart disease: results from the combined EUROASPIRE IV and V studies Open
Aims Chronic kidney disease (CKD) is commonly asymptomatic but associated with an increased risk of recurrent cardiovascular disease (CVD) events in people with coronary heart disease (CHD). The objective of this cohort study was to invest…
View article: Implementing the 2025 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Leveraging Evidence to Push the Boundaries of Clinical Care
Implementing the 2025 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Leveraging Evidence to Push the Boundaries of Clinical Care Open
View article: Global detection and management of dysglycaemic patients with coronary artery disease results from the INTERASPIRE survey from 14 countries across six WHO regions
Global detection and management of dysglycaemic patients with coronary artery disease results from the INTERASPIRE survey from 14 countries across six WHO regions Open
Objective Dysglycaemia, defined as type 2 diabetes mellitus (T2DM) or impaired glucose tolerance (IGT), increases the cardiovascular risk and prognosis. INTERASPIRE performed in 14 countries across 6 WHO regions evaluated guideline adheren…
View article: International patterns in lipid management and implications for patients with coronary heart disease: results from the INTERASPIRE study
International patterns in lipid management and implications for patients with coronary heart disease: results from the INTERASPIRE study Open
Aims To quantify international variations in lipid-lowering therapies (LLT) use among patients with coronary heart disease (CHD) and attainment of European guideline-recommended lipid goals. Methods and results INTERASPIRE is an observatio…
View article: Integration of psychological risk modifiers on-top the SMART2-risk score for estimation of recurrent cardiovascular events in patients with atherosclerotic cardiovascular disease
Integration of psychological risk modifiers on-top the SMART2-risk score for estimation of recurrent cardiovascular events in patients with atherosclerotic cardiovascular disease Open
Background The 2021 ESC Prevention Guideline recommends the use of risk prediction models to support treatment decisions. The guideline outlines psychological factors that may modify the estimated risk. However, added predictive value of t…
View article: 2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations II: diagnostic tests and prediction models
2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations II: diagnostic tests and prediction models Open
The level of evidence (LOE) grading system for European Society of Cardiology (ESC) Clinical Practice Guidelines (CPG) classifies the quality of the evidence supporting a recommendation. However, the current taxonomy does not fully conside…
View article: Using a digital health intervention “INTERCEPT” to improve secondary prevention in coronary heart disease (CHD) patients: protocol for a mixed methods non-randomised feasibility study
Using a digital health intervention “INTERCEPT” to improve secondary prevention in coronary heart disease (CHD) patients: protocol for a mixed methods non-randomised feasibility study Open
Background Digital health interventions (DHIs) are increasingly used for the secondary prevention of cardiovascular disease (CVD). The aim of this study is to determine the feasibility of “INTERCEPT”, a co-designed DHI developed to improve…
View article: Рекомендації Європейського товариства кардіологів ESC 2024 з лікування підвищеного артеріального тиску та гіпертензії
Рекомендації Європейського товариства кардіологів ESC 2024 з лікування підвищеного артеріального тиску та гіпертензії Open
No abstract
View article: Implementation of cardiovascular prevention guidelines in clinical practice. Results from the POLASPIRE II survey
Implementation of cardiovascular prevention guidelines in clinical practice. Results from the POLASPIRE II survey Open
There is considerable opportunity of further reduction of cardiovascular risk in Polish patients treated for coronary artery disease. A revision of the ongoing and more intensive endorsement of cardiovascular prevention programs is advisab…
View article: Cardiac Rehabilitation in Patients with Coronary Heart Disease – Provision, Attendance, and Outcomes: Results from the INTERASPIRE Survey from Fourteen Countries Across Six WHO Regions
Cardiac Rehabilitation in Patients with Coronary Heart Disease – Provision, Attendance, and Outcomes: Results from the INTERASPIRE Survey from Fourteen Countries Across Six WHO Regions Open
INTERASPIRE provides a standardised international picture of CR provision and attendance in patients with CHD. Despite CR being a Class 1 recommendation in all international guidelines, only one third of CHD patients reported being advised…
View article: Advancing translational research in digital cardiac rehabilitation: The preparation phase of the Multiphase Optimization Strategy
Advancing translational research in digital cardiac rehabilitation: The preparation phase of the Multiphase Optimization Strategy Open
While digital cardiac rehabilitation (CR) is an effective alternative to center-based CR, its components and mechanisms of change remain poorly understood. The Multiphase Optimization Strategy (MOST) provides a framework that allows the ef…
View article: Supporting GPs and people with hypertension to maximise medication use to control blood pressure: a pilot cluster RCT of the MIAMI intervention
Supporting GPs and people with hypertension to maximise medication use to control blood pressure: a pilot cluster RCT of the MIAMI intervention Open
View article: 2024 ESC Guidelines for the management of elevated blood pressure and hypertension: what is new in pharmacotherapy?
2024 ESC Guidelines for the management of elevated blood pressure and hypertension: what is new in pharmacotherapy? Open
View article: The ‘ten commandments’ for the 2024 European Society of Cardiology guidelines on elevated blood pressure and hypertension
The ‘ten commandments’ for the 2024 European Society of Cardiology guidelines on elevated blood pressure and hypertension Open
View article: Semaglutide and blood pressure: an individual patient data meta-analysis
Semaglutide and blood pressure: an individual patient data meta-analysis Open
Background and Aims Randomized clinical trials (RCTs) assessing semaglutide reported reductions of systolic blood pressure (SBP) in trial populations with baseline blood pressure in the normotensive range. This study aimed to determine whe…
View article: Risk prediction of cardiovascular disease in the Asia-Pacific region: the SCORE2 Asia-Pacific model
Risk prediction of cardiovascular disease in the Asia-Pacific region: the SCORE2 Asia-Pacific model Open
Background and Aims To improve upon the estimation of 10-year cardiovascular disease (CVD) event risk for individuals without prior CVD or diabetes mellitus in the Asia-Pacific region by systematic recalibration of the SCORE2 risk algorith…
View article: 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases Open
peer reviewed
View article: Variation in secondary prevention of coronary heart disease: the INTERASPIRE study
Variation in secondary prevention of coronary heart disease: the INTERASPIRE study Open
Background and Aims INTERASPIRE is an international study of coronary heart disease (CHD) patients, designed to measure if guideline standards for secondary prevention and cardiac rehabilitation are being achieved in a timely manner. Metho…
View article: 2024 ESC Guidelines for the management of chronic coronary syndromes
2024 ESC Guidelines for the management of chronic coronary syndromes Open
View article: 2024 ESC Guidelines for the management of elevated blood pressure and hypertension
2024 ESC Guidelines for the management of elevated blood pressure and hypertension Open
View article: Development of a Digital Health Intervention for the Secondary Prevention of Cardiovascular Disease (INTERCEPT): Co-Design and Usability Testing Study
Development of a Digital Health Intervention for the Secondary Prevention of Cardiovascular Disease (INTERCEPT): Co-Design and Usability Testing Study Open
Background Secondary prevention is an important strategy to reduce the burden of cardiovascular disease (CVD), a leading cause of death worldwide. Despite the growing evidence for the effectiveness of digital health interventions (DHIs) fo…
View article: Predicting Incident CVD Risk With High-Sensitivity Cardiac Troponin
Predicting Incident CVD Risk With High-Sensitivity Cardiac Troponin Open
[Figure: see text]